These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23266251)

  • 41. Impact of physical activity, cardiorespiratory fitness, and exercise training on markers of inflammation.
    Lavie CJ; Church TS; Milani RV; Earnest CP
    J Cardiopulm Rehabil Prev; 2011; 31(3):137-45. PubMed ID: 21427600
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The predictive value of C-reactive protein in end-stage renal disease: is it clinically significant?
    van der Sande FM; Kooman JP; Leunissen KM
    Blood Purif; 2006; 24(4):335-41. PubMed ID: 16557022
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Atherosclerosis and inflammation: the role of C-reactive protein].
    Ablij HC; Meinders AE
    Ned Tijdschr Geneeskd; 2003 Jan; 147(1):15-20. PubMed ID: 12564292
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

  • 45. G-CSF exerts dual effects on endothelial cells--opposing actions of direct eNOS induction versus indirect CRP elevation.
    Park KW; Kwon YW; Cho HJ; Shin JI; Kim YJ; Lee SE; Youn SW; Lee HC; Kang HJ; Shaul PW; Oh BH; Park YB; Kim HS
    J Mol Cell Cardiol; 2008 Nov; 45(5):670-8. PubMed ID: 18675273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-sensitivity C-reactive protein is the most effective prognostic measurement of acute coronary events.
    Futterman LG; Lemberg L
    Am J Crit Care; 2002 Sep; 11(5):482-6. PubMed ID: 12233975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Native C-reactive protein induces endothelial dysfunction in ApoE-/- mice: implications for iNOS and reactive oxygen species.
    Schwedler SB; Kuhlencordt PJ; Ponnuswamy PP; Hatiboglu G; Quaschning T; Widder J; Wanner C; Potempa LA; Galle J
    Atherosclerosis; 2007 Dec; 195(2):e76-84. PubMed ID: 17669410
    [TBL] [Abstract][Full Text] [Related]  

  • 48. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Paul A; Ko KW; Li L; Yechoor V; McCrory MA; Szalai AJ; Chan L
    Circulation; 2004 Feb; 109(5):647-55. PubMed ID: 14744975
    [TBL] [Abstract][Full Text] [Related]  

  • 49. C-reactive protein promotes monocyte chemoattractant protein-1--mediated chemotaxis through upregulating CC chemokine receptor 2 expression in human monocytes.
    Han KH; Hong KH; Park JH; Ko J; Kang DH; Choi KJ; Hong MK; Park SW; Park SJ
    Circulation; 2004 Jun; 109(21):2566-71. PubMed ID: 15136507
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-sensitive C-reactive protein: universal prognostic and causative biomarker in heart disease?
    Rietzschel E; De Buyzere M
    Biomark Med; 2012 Feb; 6(1):19-34. PubMed ID: 22296194
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Instability mechanisms in unstable angina according to baseline serum levels of C-reactive protein: the role of thrombosis, fibrinolysis and atherosclerotic burden.
    Niccoli G; Biasucci LM; Biscione C; Buffon A; Siviglia M; Conte M; Porto I; Graziani F; Liuzzo G; Crea F
    Int J Cardiol; 2007 Nov; 122(3):245-7. PubMed ID: 17270293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The evolving role of C-reactive protein in atherothrombosis.
    Devaraj S; Singh U; Jialal I
    Clin Chem; 2009 Feb; 55(2):229-38. PubMed ID: 19095731
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel clinical markers of vascular wall inflammation.
    Blake GJ; Ridker PM
    Circ Res; 2001 Oct; 89(9):763-71. PubMed ID: 11679405
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role.
    Venugopal SK; Devaraj S; Jialal I
    Curr Opin Nephrol Hypertens; 2005 Jan; 14(1):33-7. PubMed ID: 15586013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence for C-reactive protein's role in (CRP) vascular disease: atherothrombosis, immuno-regulation and CRP.
    Mazer SP; Rabbani LE
    J Thromb Thrombolysis; 2004 Apr; 17(2):95-105. PubMed ID: 15306744
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The emerging role of lipidomics.
    Stock J
    Atherosclerosis; 2012 Mar; 221(1):38-40. PubMed ID: 22178427
    [No Abstract]   [Full Text] [Related]  

  • 57. C-reactive protein and atherogenesis: from fatty streak to clinical event.
    Bisoendial RJ; Kastelein JJ; Stroes ES
    Atherosclerosis; 2007 Dec; 195(2):e10-8. PubMed ID: 17669411
    [TBL] [Abstract][Full Text] [Related]  

  • 58. C-reactive protein in human atherogenesis: facts and fiction.
    Zimmermann O; Li K; Zaczkiewicz M; Graf M; Liu Z; Torzewski J
    Mediators Inflamm; 2014; 2014():561428. PubMed ID: 24799767
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sources of CRP in atherosclerotic lesions.
    Jialal I; Devaraj S; Singh U
    Am J Pathol; 2006 Mar; 168(3):1054-5; author reply 1055-6. PubMed ID: 16507918
    [No Abstract]   [Full Text] [Related]  

  • 60. Proteomic and metabolomic profiles in atherothrombotic vascular disease.
    Martinez-Pinna R; Barbas C; Blanco-Colio LM; Tunon J; Ramos-Mozo P; Lopez JA; Meilhac O; Michel JB; Egido J; Martin-Ventura JL
    Curr Atheroscler Rep; 2010 May; 12(3):202-8. PubMed ID: 20425260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.